756 related articles for article (PubMed ID: 11995477)
1. Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C.
Luo JC; Hwang SJ; Chang FY; Chu CW; Lai CR; Wang YJ; Lee PC; Tsay SH; Lee SD
Hepatogastroenterology; 2002; 49(44):478-81. PubMed ID: 11995477
[TBL] [Abstract][Full Text] [Related]
2. Serum aminotransferase levels and platelet counts as predictors of degree of fibrosis in chronic hepatitis C virus infection.
Pohl A; Behling C; Oliver D; Kilani M; Monson P; Hassanein T
Am J Gastroenterol; 2001 Nov; 96(11):3142-6. PubMed ID: 11721762
[TBL] [Abstract][Full Text] [Related]
3. AST/ALT ratio predicts cirrhosis in patients with chronic hepatitis C virus infection.
Sheth SG; Flamm SL; Gordon FD; Chopra S
Am J Gastroenterol; 1998 Jan; 93(1):44-8. PubMed ID: 9448172
[TBL] [Abstract][Full Text] [Related]
4. 13C-methacetin-breath test compared to also noninvasive biochemical blood tests in predicting hepatic fibrosis and cirrhosis in chronic hepatitis C.
Dinesen L; Caspary WF; Chapman RW; Dietrich CF; Sarrazin C; Braden B
Dig Liver Dis; 2008 Sep; 40(9):743-8. PubMed ID: 18339592
[TBL] [Abstract][Full Text] [Related]
5. [Evaluation of non-invasive indices for liver histology in patients with chronic hepatitis B].
Chen YP; Zhu YF; Feng XR; Peng J; Hou JL
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1181-3. PubMed ID: 15485795
[TBL] [Abstract][Full Text] [Related]
6. Comparison and validation of simple noninvasive tests for prediction of fibrosis in chronic hepatitis C.
Lackner C; Struber G; Liegl B; Leibl S; Ofner P; Bankuti C; Bauer B; Stauber RE
Hepatology; 2005 Jun; 41(6):1376-82. PubMed ID: 15915455
[TBL] [Abstract][Full Text] [Related]
7. The 1-year and 3-month prognostic utility of the AST/ALT ratio and model for end-stage liver disease score in patients with viral liver cirrhosis.
Giannini E; Botta F; Testa E; Romagnoli P; Polegato S; Malfatti F; Fumagalli A; Chiarbonello B; Risso D; Testa R
Am J Gastroenterol; 2002 Nov; 97(11):2855-60. PubMed ID: 12425560
[TBL] [Abstract][Full Text] [Related]
8. Comparison of simple tests for the non-invasive diagnosis of clinically silent cirrhosis in chronic hepatitis C.
Borroni G; Ceriani R; Cazzaniga M; Tommasini M; Roncalli M; Maltempo C; Felline C; Salerno F
Aliment Pharmacol Ther; 2006 Sep; 24(5):797-804. PubMed ID: 16918883
[TBL] [Abstract][Full Text] [Related]
9. Is there any non-invasive marker replace the needle liver biopsy predictive for liver fibrosis, in patients with chronic hepatitis?
Vardar R; Vardar E; Demiri S; Sayhan SE; Bayol U; Yildiz C; Postaci H
Hepatogastroenterology; 2009; 56(94-95):1459-65. PubMed ID: 19950810
[TBL] [Abstract][Full Text] [Related]
10. Noninvasive serum markers in the diagnosis of structural liver damage in chronic hepatitis C virus infection.
Parise ER; Oliveira AC; Figueiredo-Mendes C; Lanzoni V; Martins J; Nader H; Ferraz ML
Liver Int; 2006 Nov; 26(9):1095-9. PubMed ID: 17032410
[TBL] [Abstract][Full Text] [Related]
11. Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation.
Toniutto P; Fabris C; Bitetto D; Falleti E; Avellini C; Rossi E; Smirne C; Minisini R; Pirisi M
J Gastroenterol Hepatol; 2007 Nov; 22(11):1904-8. PubMed ID: 17914968
[TBL] [Abstract][Full Text] [Related]
12. A practical scoring system for predicting cirrhosis in patients with chronic viral hepatitis.
Cheong JY; Um SH; Seo YS; Shin SS; Park RW; Kim DJ; Hwang SG; Lee YJ; Cho M; Yang JM; Kim YB; Park YN; Cho SW
Hepatogastroenterology; 2012; 59(120):2592-7. PubMed ID: 23178625
[TBL] [Abstract][Full Text] [Related]
13. Serum fibrosis markers identify patients with mild and progressive hepatitis C recurrence after liver transplantation.
Carrión JA; Fernández-Varo G; Bruguera M; García-Pagán JC; García-Valdecasas JC; Pérez-Del-Pulgar S; Forns X; Jiménez W; Navasa M
Gastroenterology; 2010 Jan; 138(1):147-58.e1. PubMed ID: 19786026
[TBL] [Abstract][Full Text] [Related]
14. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
[TBL] [Abstract][Full Text] [Related]
15. Cirrhosis in hepatitis C virus-infected patients can be excluded using an index of standard biochemical serum markers.
Islam S; Antonsson L; Westin J; Lagging M
Scand J Gastroenterol; 2005 Jul; 40(7):867-72. PubMed ID: 16109665
[TBL] [Abstract][Full Text] [Related]
16. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
[TBL] [Abstract][Full Text] [Related]
17. Need for validation of clinical decision aids: use of the AST/ALT ratio in predicting cirrhosis in chronic hepatitis C.
Imperiale TF; Said AT; Cummings OW; Born LJ
Am J Gastroenterol; 2000 Sep; 95(9):2328-32. PubMed ID: 11007237
[TBL] [Abstract][Full Text] [Related]
18. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC.
Nyblom H; Björnsson E; Simrén M; Aldenborg F; Almer S; Olsson R
Liver Int; 2006 Sep; 26(7):840-5. PubMed ID: 16911467
[TBL] [Abstract][Full Text] [Related]
19. [Screening and evaluation of non-invasive diagnosis markers for compensated liver cirrhosis in patients with chronic hepatitis B].
Chen YP; Feng XR; Dai L; Ding HB; Zhang L
Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):225-7. PubMed ID: 12716522
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of non-invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B.
Lee KG; Seo YS; An H; Um SH; Jung ES; Keum B; Yim HJ; Jeen YT; Chun HJ; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2010 Jan; 25(1):94-100. PubMed ID: 19793171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
